U.K. stocks increased Tuesday, as the FTSE 100 Index closed up 0.58% at 7,675.21. Among FTSE 100 constituents, residential building construction company.
The drugmaker says the trial demonstrated a statistically significant and clinically meaningful improvement for the primary endpoint of progression-free.
By Christian Moess Laursen AstraZeneca said its lung-cancer drug Enhertu has been recommended for approval in the European Union following positive test.
By Anthony O. Goriainoff AstraZeneca and Daiichi Sankyo said that datopotamab deruxtecan, a cancer drug, combined with the Imfinzi cancer treatment with or.
U.K. stocks finished higher Monday, with the FTSE 100 Index rising 0.25% at 7,496.87. Of the FTSE 100 constituents, precious metals company Fresnillo PLC saw.